Hilleman Laboratories was established in 2009 as an equal joint venture between Merck Sharp & Dohme Corp. (MSD), a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to health. Hilleman Laboratories’ mission is to develop affordable vaccines and biologics against infectious diseases that affect low- and middle-income countries.
Hilleman Laboratories is establishing a first-of-its-kind vaccine and biologics development and manufacturing hub in Singapore comprising a 30,000 square foot current Good Manufacturing Practices (cGMP) facility and a state-of-the-art research and development facility.
Company Details
- Employees
- 75
- Founded
- -
- Address
- 21 Biopolis Road, Nucleos North Tower #04-06/12,singapore
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.hilleman-labs.org
- Keywords
- vaccines, biologics, biotechnology, biomedical, chemistry, bioassays, applied science, molecular biology, medical biology, mammalian, process development, research and development, biopharma.
- HQ
- Singapore
Hilleman Laboratories Questions
Hilleman Laboratories's website is http://www.hilleman-labs.org
Hilleman Laboratories's LinkedIn profile is https://sg.linkedin.com/company/hilleman-laboratories
Hilleman Laboratories has
75 employees.
View email and phone details for 75
employees at Hilleman Laboratories.
Hilleman Laboratories's industry is
Research Services
Hilleman Laboratories's top competitors are
Cellvec Pte Ltd,
Wellcome Trust,
Lucence,
Mirxes,
Sanofi,
Hummingbird Bioscience,
Msd,
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics),
Bharat Biotech,
Tessa Therapeutics Ltd.
Hilleman Laboratories's categories are Research Services
Hilleman Laboratories's founding year is 2021
